Focal Segmental Glomerulosclerosis (FSGS) Market, Global Outlook and Forecast 2022-2028
Focal Segmental Glomerulosclerosis (FSGS) is a cause of nephrotic syndrome in children and adolescents, as well as a leading cause of kidney failure in adults.
This report contains market size and forecasts of Focal Segmental Glomerulosclerosis (FSGS) in global, including the following market information:
Global Focal Segmental Glomerulosclerosis (FSGS) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Focal Segmental Glomerulosclerosis (FSGS) Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Focal Segmental Glomerulosclerosis (FSGS) companies in 2021 (%)
The global Focal Segmental Glomerulosclerosis (FSGS) market was valued at 7200.6 million in 2021 and is projected to reach US$ 9610.7 million by 2028, at a CAGR of 4.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnosis (Kidney Biopsy and Creatine Test) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Focal Segmental Glomerulosclerosis (FSGS) include Variant Pharmaceuticals, ChemoCentryx, Retrophin, Novartis, Pfizer, AstraZeneca, Sanofi, GlaxoSmithKline and Teva Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Focal Segmental Glomerulosclerosis (FSGS) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Focal Segmental Glomerulosclerosis (FSGS) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Focal Segmental Glomerulosclerosis (FSGS) Market Segment Percentages, by Type, 2021 (%)
Global Focal Segmental Glomerulosclerosis (FSGS) Market Segment Percentages, by Application, 2021 (%)
Global Focal Segmental Glomerulosclerosis (FSGS) Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Focal Segmental Glomerulosclerosis (FSGS) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Focal Segmental Glomerulosclerosis (FSGS) revenues share in global market, 2021 (%)
Key companies Focal Segmental Glomerulosclerosis (FSGS) sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Focal Segmental Glomerulosclerosis (FSGS) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Focal Segmental Glomerulosclerosis (FSGS) in global, including the following market information:
Global Focal Segmental Glomerulosclerosis (FSGS) Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Focal Segmental Glomerulosclerosis (FSGS) Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Focal Segmental Glomerulosclerosis (FSGS) companies in 2021 (%)
The global Focal Segmental Glomerulosclerosis (FSGS) market was valued at 7200.6 million in 2021 and is projected to reach US$ 9610.7 million by 2028, at a CAGR of 4.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Diagnosis (Kidney Biopsy and Creatine Test) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Focal Segmental Glomerulosclerosis (FSGS) include Variant Pharmaceuticals, ChemoCentryx, Retrophin, Novartis, Pfizer, AstraZeneca, Sanofi, GlaxoSmithKline and Teva Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Focal Segmental Glomerulosclerosis (FSGS) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Focal Segmental Glomerulosclerosis (FSGS) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Focal Segmental Glomerulosclerosis (FSGS) Market Segment Percentages, by Type, 2021 (%)
- Diagnosis (Kidney Biopsy and Creatine Test)
- Treatment (Drug Therapy, Dialysis, and Kidney Transplant)
Global Focal Segmental Glomerulosclerosis (FSGS) Market Segment Percentages, by Application, 2021 (%)
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Global Focal Segmental Glomerulosclerosis (FSGS) Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Focal Segmental Glomerulosclerosis (FSGS) revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Focal Segmental Glomerulosclerosis (FSGS) revenues share in global market, 2021 (%)
Key companies Focal Segmental Glomerulosclerosis (FSGS) sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Focal Segmental Glomerulosclerosis (FSGS) sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Variant Pharmaceuticals
- ChemoCentryx
- Retrophin
- Novartis
- Pfizer
- AstraZeneca
- Sanofi
- GlaxoSmithKline
- Teva Pharmaceutical
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Focal Segmental Glomerulosclerosis (FSGS) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Focal Segmental Glomerulosclerosis (FSGS) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) OVERALL MARKET SIZE
2.1 Global Focal Segmental Glomerulosclerosis (FSGS) Market Size: 2021 VS 2028
2.2 Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Focal Segmental Glomerulosclerosis (FSGS) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Focal Segmental Glomerulosclerosis (FSGS) Players in Global Market
3.2 Top Global Focal Segmental Glomerulosclerosis (FSGS) Companies Ranked by Revenue
3.3 Global Focal Segmental Glomerulosclerosis (FSGS) Revenue by Companies
3.4 Global Focal Segmental Glomerulosclerosis (FSGS) Sales by Companies
3.5 Global Focal Segmental Glomerulosclerosis (FSGS) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Focal Segmental Glomerulosclerosis (FSGS) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Focal Segmental Glomerulosclerosis (FSGS) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Focal Segmental Glomerulosclerosis (FSGS) Players in Global Market
3.8.1 List of Global Tier 1 Focal Segmental Glomerulosclerosis (FSGS) Companies
3.8.2 List of Global Tier 2 and Tier 3 Focal Segmental Glomerulosclerosis (FSGS) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Market Size Markets, 2021 & 2028
4.1.2 Diagnosis (Kidney Biopsy and Creatine Test)
4.1.3 Treatment (Drug Therapy, Dialysis, and Kidney Transplant)
4.2 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue & Forecasts
4.2.1 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2022
4.2.2 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2023-2028
4.2.3 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
4.3 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales & Forecasts
4.3.1 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2022
4.3.2 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales, 2023-2028
4.3.3 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
4.4 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Specialty Clinics
5.2 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue & Forecasts
5.2.1 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2022
5.2.2 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2023-2028
5.2.3 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
5.3 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales & Forecasts
5.3.1 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2022
5.3.2 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales, 2023-2028
5.3.3 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
5.4 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2021 & 2028
6.2 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue & Forecasts
6.2.1 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2022
6.2.2 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2023-2028
6.2.3 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
6.3 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales & Forecasts
6.3.1 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2022
6.3.2 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales, 2023-2028
6.3.3 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2028
6.4.2 By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2028
6.4.3 US Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.4.4 Canada Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.4.5 Mexico Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2028
6.5.2 By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2028
6.5.3 Germany Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5.4 France Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5.5 U.K. Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5.6 Italy Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5.7 Russia Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5.8 Nordic Countries Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5.9 Benelux Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2028
6.6.2 By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2028
6.6.3 China Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.6.4 Japan Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.6.5 South Korea Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.6.6 Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.6.7 India Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2028
6.7.2 By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2028
6.7.3 Brazil Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.7.4 Argentina Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2028
6.8.3 Turkey Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.8.4 Israel Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.8.5 Saudi Arabia Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.8.6 UAE Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Variant Pharmaceuticals
7.1.1 Variant Pharmaceuticals Corporate Summary
7.1.2 Variant Pharmaceuticals Business Overview
7.1.3 Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.1.4 Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.1.5 Variant Pharmaceuticals Key News
7.2 ChemoCentryx
7.2.1 ChemoCentryx Corporate Summary
7.2.2 ChemoCentryx Business Overview
7.2.3 ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.2.4 ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.2.5 ChemoCentryx Key News
7.3 Retrophin
7.3.1 Retrophin Corporate Summary
7.3.2 Retrophin Business Overview
7.3.3 Retrophin Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.3.4 Retrophin Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.3.5 Retrophin Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.4.4 Novartis Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.4.5 Novartis Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.5.4 Pfizer Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.6.4 AstraZeneca Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.7.4 Sanofi Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.7.5 Sanofi Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.8.4 GlaxoSmithKline Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.8.5 GlaxoSmithKline Key News
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Corporate Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.9.4 Teva Pharmaceutical Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.9.5 Teva Pharmaceutical Key News
8 GLOBAL FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Focal Segmental Glomerulosclerosis (FSGS) Production Capacity, 2017-2028
8.2 Focal Segmental Glomerulosclerosis (FSGS) Production Capacity of Key Manufacturers in Global Market
8.3 Global Focal Segmental Glomerulosclerosis (FSGS) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) SUPPLY CHAIN ANALYSIS
10.1 Focal Segmental Glomerulosclerosis (FSGS) Industry Value Chain
10.2 Focal Segmental Glomerulosclerosis (FSGS) Upstream Market
10.3 Focal Segmental Glomerulosclerosis (FSGS) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Focal Segmental Glomerulosclerosis (FSGS) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Focal Segmental Glomerulosclerosis (FSGS) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Focal Segmental Glomerulosclerosis (FSGS) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) OVERALL MARKET SIZE
2.1 Global Focal Segmental Glomerulosclerosis (FSGS) Market Size: 2021 VS 2028
2.2 Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Focal Segmental Glomerulosclerosis (FSGS) Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Focal Segmental Glomerulosclerosis (FSGS) Players in Global Market
3.2 Top Global Focal Segmental Glomerulosclerosis (FSGS) Companies Ranked by Revenue
3.3 Global Focal Segmental Glomerulosclerosis (FSGS) Revenue by Companies
3.4 Global Focal Segmental Glomerulosclerosis (FSGS) Sales by Companies
3.5 Global Focal Segmental Glomerulosclerosis (FSGS) Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Focal Segmental Glomerulosclerosis (FSGS) Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Focal Segmental Glomerulosclerosis (FSGS) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Focal Segmental Glomerulosclerosis (FSGS) Players in Global Market
3.8.1 List of Global Tier 1 Focal Segmental Glomerulosclerosis (FSGS) Companies
3.8.2 List of Global Tier 2 and Tier 3 Focal Segmental Glomerulosclerosis (FSGS) Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Market Size Markets, 2021 & 2028
4.1.2 Diagnosis (Kidney Biopsy and Creatine Test)
4.1.3 Treatment (Drug Therapy, Dialysis, and Kidney Transplant)
4.2 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue & Forecasts
4.2.1 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2022
4.2.2 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2023-2028
4.2.3 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
4.3 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales & Forecasts
4.3.1 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2022
4.3.2 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales, 2023-2028
4.3.3 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
4.4 By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Specialty Clinics
5.2 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue & Forecasts
5.2.1 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2022
5.2.2 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2023-2028
5.2.3 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
5.3 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales & Forecasts
5.3.1 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2022
5.3.2 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales, 2023-2028
5.3.3 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
5.4 By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2021 & 2028
6.2 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue & Forecasts
6.2.1 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2022
6.2.2 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2023-2028
6.2.3 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
6.3 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales & Forecasts
6.3.1 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2022
6.3.2 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales, 2023-2028
6.3.3 By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2028
6.4.2 By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2028
6.4.3 US Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.4.4 Canada Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.4.5 Mexico Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2028
6.5.2 By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2028
6.5.3 Germany Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5.4 France Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5.5 U.K. Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5.6 Italy Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5.7 Russia Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5.8 Nordic Countries Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.5.9 Benelux Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2028
6.6.2 By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2028
6.6.3 China Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.6.4 Japan Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.6.5 South Korea Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.6.6 Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.6.7 India Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2028
6.7.2 By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2028
6.7.3 Brazil Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.7.4 Argentina Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales, 2017-2028
6.8.3 Turkey Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.8.4 Israel Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.8.5 Saudi Arabia Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
6.8.6 UAE Focal Segmental Glomerulosclerosis (FSGS) Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Variant Pharmaceuticals
7.1.1 Variant Pharmaceuticals Corporate Summary
7.1.2 Variant Pharmaceuticals Business Overview
7.1.3 Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.1.4 Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.1.5 Variant Pharmaceuticals Key News
7.2 ChemoCentryx
7.2.1 ChemoCentryx Corporate Summary
7.2.2 ChemoCentryx Business Overview
7.2.3 ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.2.4 ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.2.5 ChemoCentryx Key News
7.3 Retrophin
7.3.1 Retrophin Corporate Summary
7.3.2 Retrophin Business Overview
7.3.3 Retrophin Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.3.4 Retrophin Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.3.5 Retrophin Key News
7.4 Novartis
7.4.1 Novartis Corporate Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.4.4 Novartis Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.4.5 Novartis Key News
7.5 Pfizer
7.5.1 Pfizer Corporate Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.5.4 Pfizer Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.5.5 Pfizer Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.6.4 AstraZeneca Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Sanofi
7.7.1 Sanofi Corporate Summary
7.7.2 Sanofi Business Overview
7.7.3 Sanofi Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.7.4 Sanofi Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.7.5 Sanofi Key News
7.8 GlaxoSmithKline
7.8.1 GlaxoSmithKline Corporate Summary
7.8.2 GlaxoSmithKline Business Overview
7.8.3 GlaxoSmithKline Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.8.4 GlaxoSmithKline Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.8.5 GlaxoSmithKline Key News
7.9 Teva Pharmaceutical
7.9.1 Teva Pharmaceutical Corporate Summary
7.9.2 Teva Pharmaceutical Business Overview
7.9.3 Teva Pharmaceutical Focal Segmental Glomerulosclerosis (FSGS) Major Product Offerings
7.9.4 Teva Pharmaceutical Focal Segmental Glomerulosclerosis (FSGS) Sales and Revenue in Global (2017-2022)
7.9.5 Teva Pharmaceutical Key News
8 GLOBAL FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) PRODUCTION CAPACITY, ANALYSIS
8.1 Global Focal Segmental Glomerulosclerosis (FSGS) Production Capacity, 2017-2028
8.2 Focal Segmental Glomerulosclerosis (FSGS) Production Capacity of Key Manufacturers in Global Market
8.3 Global Focal Segmental Glomerulosclerosis (FSGS) Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 FOCAL SEGMENTAL GLOMERULOSCLEROSIS (FSGS) SUPPLY CHAIN ANALYSIS
10.1 Focal Segmental Glomerulosclerosis (FSGS) Industry Value Chain
10.2 Focal Segmental Glomerulosclerosis (FSGS) Upstream Market
10.3 Focal Segmental Glomerulosclerosis (FSGS) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Focal Segmental Glomerulosclerosis (FSGS) Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Focal Segmental Glomerulosclerosis (FSGS) in Global Market
Table 2. Top Focal Segmental Glomerulosclerosis (FSGS) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Share by Companies, 2017-2022
Table 5. Global Focal Segmental Glomerulosclerosis (FSGS) Sales by Companies, (Kg), 2017-2022
Table 6. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Focal Segmental Glomerulosclerosis (FSGS) Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Focal Segmental Glomerulosclerosis (FSGS) Product Type
Table 9. List of Global Tier 1 Focal Segmental Glomerulosclerosis (FSGS) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Focal Segmental Glomerulosclerosis (FSGS) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), 2017-2022
Table 15. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), 2023-2028
Table 16. By Application – Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), 2017-2022
Table 20. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), 2023-2028
Table 21. By Region – Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), 2017-2022
Table 25. By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), 2023-2028
Table 26. By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2017-2022
Table 29. By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2023-2028
Table 30. By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2017-2022
Table 33. By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2023-2028
Table 34. By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2017-2022
Table 37. By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2023-2028
Table 38. By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2017-2022
Table 41. By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2023-2028
Table 46. Variant Pharmaceuticals Corporate Summary
Table 47. Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 48. Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. ChemoCentryx Corporate Summary
Table 50. ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 51. ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Retrophin Corporate Summary
Table 53. Retrophin Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 54. Retrophin Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Novartis Corporate Summary
Table 56. Novartis Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 57. Novartis Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 60. Pfizer Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. AstraZeneca Corporate Summary
Table 62. AstraZeneca Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 63. AstraZeneca Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. Sanofi Corporate Summary
Table 65. Sanofi Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 66. Sanofi Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. GlaxoSmithKline Corporate Summary
Table 68. GlaxoSmithKline Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 69. GlaxoSmithKline Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 70. Teva Pharmaceutical Corporate Summary
Table 71. Teva Pharmaceutical Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 72. Teva Pharmaceutical Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 73. Focal Segmental Glomerulosclerosis (FSGS) Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 74. Global Focal Segmental Glomerulosclerosis (FSGS) Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Focal Segmental Glomerulosclerosis (FSGS) Production by Region, 2017-2022 (Kg)
Table 76. Global Focal Segmental Glomerulosclerosis (FSGS) Production by Region, 2023-2028 (Kg)
Table 77. Focal Segmental Glomerulosclerosis (FSGS) Market Opportunities & Trends in Global Market
Table 78. Focal Segmental Glomerulosclerosis (FSGS) Market Drivers in Global Market
Table 79. Focal Segmental Glomerulosclerosis (FSGS) Market Restraints in Global Market
Table 80. Focal Segmental Glomerulosclerosis (FSGS) Raw Materials
Table 81. Focal Segmental Glomerulosclerosis (FSGS) Raw Materials Suppliers in Global Market
Table 82. Typical Focal Segmental Glomerulosclerosis (FSGS) Downstream
Table 83. Focal Segmental Glomerulosclerosis (FSGS) Downstream Clients in Global Market
Table 84. Focal Segmental Glomerulosclerosis (FSGS) Distributors and Sales Agents in Global Market
Table 1. Key Players of Focal Segmental Glomerulosclerosis (FSGS) in Global Market
Table 2. Top Focal Segmental Glomerulosclerosis (FSGS) Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Share by Companies, 2017-2022
Table 5. Global Focal Segmental Glomerulosclerosis (FSGS) Sales by Companies, (Kg), 2017-2022
Table 6. Global Focal Segmental Glomerulosclerosis (FSGS) Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Focal Segmental Glomerulosclerosis (FSGS) Price (2017-2022) & (USD/Kg)
Table 8. Global Manufacturers Focal Segmental Glomerulosclerosis (FSGS) Product Type
Table 9. List of Global Tier 1 Focal Segmental Glomerulosclerosis (FSGS) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Focal Segmental Glomerulosclerosis (FSGS) Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), 2017-2022
Table 15. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), 2023-2028
Table 16. By Application – Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), 2017-2022
Table 20. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), 2023-2028
Table 21. By Region – Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), 2017-2022
Table 25. By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), 2023-2028
Table 26. By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2017-2022
Table 29. By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2023-2028
Table 30. By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2017-2022
Table 33. By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2023-2028
Table 34. By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2017-2022
Table 37. By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2023-2028
Table 38. By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2017-2022
Table 41. By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2023-2028
Table 42. By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2017-2022
Table 45. By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales, (Kg), 2023-2028
Table 46. Variant Pharmaceuticals Corporate Summary
Table 47. Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 48. Variant Pharmaceuticals Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 49. ChemoCentryx Corporate Summary
Table 50. ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 51. ChemoCentryx Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 52. Retrophin Corporate Summary
Table 53. Retrophin Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 54. Retrophin Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 55. Novartis Corporate Summary
Table 56. Novartis Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 57. Novartis Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 58. Pfizer Corporate Summary
Table 59. Pfizer Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 60. Pfizer Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 61. AstraZeneca Corporate Summary
Table 62. AstraZeneca Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 63. AstraZeneca Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 64. Sanofi Corporate Summary
Table 65. Sanofi Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 66. Sanofi Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 67. GlaxoSmithKline Corporate Summary
Table 68. GlaxoSmithKline Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 69. GlaxoSmithKline Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 70. Teva Pharmaceutical Corporate Summary
Table 71. Teva Pharmaceutical Focal Segmental Glomerulosclerosis (FSGS) Product Offerings
Table 72. Teva Pharmaceutical Focal Segmental Glomerulosclerosis (FSGS) Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2017-2022)
Table 73. Focal Segmental Glomerulosclerosis (FSGS) Production Capacity (Kg) of Key Manufacturers in Global Market, 2020-2022 (Kg)
Table 74. Global Focal Segmental Glomerulosclerosis (FSGS) Capacity Market Share of Key Manufacturers, 2020-2022
Table 75. Global Focal Segmental Glomerulosclerosis (FSGS) Production by Region, 2017-2022 (Kg)
Table 76. Global Focal Segmental Glomerulosclerosis (FSGS) Production by Region, 2023-2028 (Kg)
Table 77. Focal Segmental Glomerulosclerosis (FSGS) Market Opportunities & Trends in Global Market
Table 78. Focal Segmental Glomerulosclerosis (FSGS) Market Drivers in Global Market
Table 79. Focal Segmental Glomerulosclerosis (FSGS) Market Restraints in Global Market
Table 80. Focal Segmental Glomerulosclerosis (FSGS) Raw Materials
Table 81. Focal Segmental Glomerulosclerosis (FSGS) Raw Materials Suppliers in Global Market
Table 82. Typical Focal Segmental Glomerulosclerosis (FSGS) Downstream
Table 83. Focal Segmental Glomerulosclerosis (FSGS) Downstream Clients in Global Market
Table 84. Focal Segmental Glomerulosclerosis (FSGS) Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Focal Segmental Glomerulosclerosis (FSGS) Segment by Type
Figure 2. Focal Segmental Glomerulosclerosis (FSGS) Segment by Application
Figure 3. Global Focal Segmental Glomerulosclerosis (FSGS) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Focal Segmental Glomerulosclerosis (FSGS) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2028 (US$, Mn)
Figure 7. Focal Segmental Glomerulosclerosis (FSGS) Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Focal Segmental Glomerulosclerosis (FSGS) Revenue in 2021
Figure 9. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 10. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 13. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 16. By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 19. US Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 24. Germany Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 25. France Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 33. China Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 37. India Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 40. Brazil Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 44. Turkey Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Focal Segmental Glomerulosclerosis (FSGS) Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Focal Segmental Glomerulosclerosis (FSGS) by Region, 2021 VS 2028
Figure 50. Focal Segmental Glomerulosclerosis (FSGS) Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Focal Segmental Glomerulosclerosis (FSGS) Segment by Type
Figure 2. Focal Segmental Glomerulosclerosis (FSGS) Segment by Application
Figure 3. Global Focal Segmental Glomerulosclerosis (FSGS) Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Focal Segmental Glomerulosclerosis (FSGS) Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Focal Segmental Glomerulosclerosis (FSGS) Revenue, 2017-2028 (US$, Mn)
Figure 7. Focal Segmental Glomerulosclerosis (FSGS) Sales in Global Market: 2017-2028 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Focal Segmental Glomerulosclerosis (FSGS) Revenue in 2021
Figure 9. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 10. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 11. By Type - Global Focal Segmental Glomerulosclerosis (FSGS) Price (USD/Kg), 2017-2028
Figure 12. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 13. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 14. By Application - Global Focal Segmental Glomerulosclerosis (FSGS) Price (USD/Kg), 2017-2028
Figure 15. By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 16. By Region - Global Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 17. By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 18. By Country - North America Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 19. US Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 24. Germany Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 25. France Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 33. China Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 37. India Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 39. By Country - South America Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 40. Brazil Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Focal Segmental Glomerulosclerosis (FSGS) Sales Market Share, 2017-2028
Figure 44. Turkey Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Focal Segmental Glomerulosclerosis (FSGS) Revenue, (US$, Mn), 2017-2028
Figure 48. Global Focal Segmental Glomerulosclerosis (FSGS) Production Capacity (Kg), 2017-2028
Figure 49. The Percentage of Production Focal Segmental Glomerulosclerosis (FSGS) by Region, 2021 VS 2028
Figure 50. Focal Segmental Glomerulosclerosis (FSGS) Industry Value Chain
Figure 51. Marketing Channels
